KIA
XERS icon

Kraematon Investment Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Kraematon Investment Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,885
Closed -$3.84K – 258
2022
Q4 		$3.84K Buy
+2,885
New +$3.84K ﹤0.01% 233